Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing XXXX in brain.

@entity1 @entity410 @entity75 @entity302
The study was conducted in 81 @entity1 of @entity302 with small single enhancing CT (SSECT) lesion in brain to determine the clinical profile and duration of antiepileptic drugs (AEDs) treatment. The @entity1 were randomly divided into group A (41 cases) and group B (40 cases). Group A @entity1 were treated for 6 months and group B for 1 year with AEDS without cysticidal drugs. The most common mode of presentation was simple partial @entity410 with secondary generalization in both the groups. Repeat imaging of brain (CT/MRI) at 6 months showed disappearance of lesion in 82.94% in group A and 87% in group B, while persistence of lesion was present only in 4.87% in group A and 5% in group B. 87.81% @entity1 in group A and 87.17% in group B were @entity410 free. The recurrence of @entity410 occurred in 12.19% cases in group A, and 12.82% in group B. 80% of these @entity1 had @entity75 in both the groups. This study reveals that SSECT lesion with epilpesy is a benign self-limiting disease. It also reveals that 6 months AED treatment is as effective as one year treatment. @entity1 having @entity75 or persistence of lesion might require long term AED treatment.
